155 related articles for article (PubMed ID: 7501355)
1. Nuchal translucency measurement in normal fetuses.
Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
[TBL] [Abstract][Full Text] [Related]
2. Weekly nuchal translucency measurements in normal fetuses.
Pajkrt E; de Graaf IM; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Obstet Gynecol; 1998 Feb; 91(2):208-11. PubMed ID: 9469277
[TBL] [Abstract][Full Text] [Related]
3. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
4. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
5. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
[TBL] [Abstract][Full Text] [Related]
7. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
[TBL] [Abstract][Full Text] [Related]
8. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
9. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
[TBL] [Abstract][Full Text] [Related]
10. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population.
Braithwaite JM; Morris RW; Economides DL
Br J Obstet Gynaecol; 1996 Dec; 103(12):1201-4. PubMed ID: 8968236
[TBL] [Abstract][Full Text] [Related]
11. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
Schaefer M; Laurichesse-Delmas H; Ville Y
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
[TBL] [Abstract][Full Text] [Related]
12. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
[TBL] [Abstract][Full Text] [Related]
13. The influence of fetal position on nuchal translucency thickness.
de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
[TBL] [Abstract][Full Text] [Related]
14. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
[TBL] [Abstract][Full Text] [Related]
15. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
16. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
17. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
[TBL] [Abstract][Full Text] [Related]
18. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation.
Salomon LJ; Bernard JP; Taupin P; Benard C; Ville Y
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):636-7. PubMed ID: 11844204
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
[TBL] [Abstract][Full Text] [Related]
20. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
